Patients with autoimmune rheumatic conditions demonstrated a 1.5-fold increased risk for long COVID after infection compared ...

Researchers in China isolated the recombinant feline coronavirus type II strain AH2023, which proved uniformly lethal in ...

Fewer than two-thirds of patients prescribed augmentation begin infusions, and half of starters miss doses. Structured ...

Cold atmospheric plasma offers a novel approach to tackle biofilm resilience, enhancing microbial killing and addressing the ...

The LP.8.1-adapted BNT162b2 COVID-19 vaccine elicited a strong immune response and showed an acceptable safety profile in ...

Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has expanded approval of TALZENNA® ...

Jill Jones, 62, from New Marston, receives immunoglobulin infusions every three weeks at the John Radcliffe Hospital.

NUBEQA® plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of ...

A systematic review of 30 studies finds photodynamic inactivation reliably destroys enveloped viruses in laboratory and blood ...

A needle-free vaccination method protected mice against the viruses that cause COVID-19 and flu, offering a possible new way to deliver mRNA vaccines while limiting unwanted inflammation.

W ith their ability to home in on precise targets while ignoring everything else, monoclonal antibodies are powerful ...

COVID-19 vaccination is linked to decreased in-hospital mortality and shorter hospital stays among patients receiving immunomodulatory therapies.